ABOUT
Smart discussion of the latest science and news on toxins in your food, water, and air, and what government agencies should be doing to protect public health. Enviroblog is a project of EWG Action Fund.
FEED
An EWG podcast for environmental health news on the go.
TIPS
Did we miss something? Email Enviroblg.
BLOGROLL
STAY CONNECTED
Get our monthly eNewsletter, action alerts, & environmental tips. [Privacy policy, About EWG]
Eco-nomics, the new kind of economics
Please don't disrupt my endocrines!
FEATURED
Please don't disrupt my endocrines!
Consumers to FDA: Be there or be square
Lead: Celebrate its ban, but don't cross it off your list
7 ways to reduce your exposure to PBDEs
Ask EWG
What can I do about fluoride in my water?
What is new carpet treated with? What can I do?
Are stainless steel water bottles safe?
Is mineral-based makeup safer?
SEARCH
« RAN's World Rainforest Week | Main | Drink me, I'm toxic »
Preschool puberty from cometics, drugs
Today the New York Times reports some disturbing news about certain drugs and cosmetics causing preschoolers to go into puberty. In one case, a girl and her brother--whose father had been using a testosterone skin cream--started growing pubic hair just from skin contact with their father. Her brother also developed some aggressive behavior problems. The article cites some 1998 cases of early breast development in young girls brought on by a shampoo which contained estrogen and placental extract.
What does the FDA have to say about this? The FDA spokesperson told the Times that FDA was “aware of some reports describing premature sexual development” and that “there is no reason for consumers to be concerned.” And at this time “placental materials are neither prohibited by cosmetic regulations nor restricted” by the FDA.
Robert Cooper, chief of endocrinology at the reproductive toxicology division of the EPA suggests that conflicts of interest on advisory panels have hampered the development of adequate testing measures for these endocrine disruptors in consumer products:
In 1996, Congress directed the E.P.A. to develop a comprehensive screening program for possible endocrine disruptors within three years. Dr. Cooper says no such program has begun operation, a failure he attributed largely to stonewalling by chemical industry representatives who serve on an advisory committee for the program. Now the proposed rollout is December 2007, but Dr. Cooper said, “They may be dreaming.” Critics cite the program’s high potential costs and lack of reliable laboratory tests.
Full article